Lucinactant (Intratracheal Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Lucinactant (Intratracheal Route)

Drug Information provided by: Micromedex

US Brand Names

  • Surfaxin

Description

Lucinactant injection is used to prevent respiratory distress syndrome (RDS) in premature infants at risk for RDS. RDS is a breathing or lung problem which is more common in premature infants because their lungs are not making enough surfactant. Surfactant is a liquid produced naturally in the lungs that helps an infant breathe air normally.

This medicine is to be given only by or under the direct supervision of a doctor.

This product is available in the following dosage forms:

  • Suspension
Before Using
DR603607 Portions of this document last updated: Oct. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger